**Experiences of Canadians with Long-Term Symptoms Following COVID-19
Despite high vaccination rates, a substantial number of adults continued to experience persistent symptoms, impacting their daily lives and healthcare utilization
Despite high vaccination rates, a substantial number of adults continued to experience persistent symptoms, impacting their daily lives and healthcare utilization
While efforts to address long COVID are underway, medical gaslighting remains a significant barrier to compassionate care. Educating healthcare professionals, raising awareness, and ensuring accessible information are crucial steps towards supporting long COVID patients and fostering inclusive, evidence-based care.
Identifying and validating diverse immune cells, cytokines, and plasma proteins as potential biomarkers for Long COVID is crucial for improving diagnosis and treatment, highlighting the need for further exploration of LC's complex etiologies through symptom clusters or sex stratification.
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
arious components such as Antithrombin III, Complement C5, and Factor B were measured at different intensities and fold changes, with a follow-up at 6 months. The study aimed to identify biomarkers associated with Long Covid and recovery.
Exploring the complexities of Post-Infectious Fatigue Syndromes reveals a landscape where diagnostic criteria overlap, prevalence data is scarce, and core symptoms persist, hinting at a shared pathophysiology underlying chronic disability post-infection.
Cognitive slowing emerges as a distinct marker in post-COVID-19 conditions, setting apart survivors with enduring symptoms. The pronounced delays observed in simple reaction time tasks signal a potential key factor contributing to cognitive impairments, marking a critical aspect of the post-COVID-19 cognitive landscape.
Centers for Disease Control and Prevention (CDC) reported that approximately 10-30% of COVID-19 patients experience prolonged symptoms.
A study suggests that individuals hospitalized with flu face a heightened risk of long-term health issues, akin to long Covid.
Researchers investigated immune and hormonal differences in individuals with Long COVID compared to those without. They found significant variations, including higher levels of specific immune cells, stronger antibody responses to SARS-CoV-2 and Epstein-Barr virus (EBV), and lower levels of the stress hormone cortisol in Long COVID patients.